Research On The Financial Benefit Of Humanwell Pharmaceutical M&A Of Three Gorges Pharmaceutical

With the development of reform and opening up,China's economy has been development rapidly.Capital operation has become increasingly active,that Mergers and acquisitions have become one of the widely used the way of enterprises.With the development of health care reform,pharmaceutical enterprises are facing opportunities and challenges.At present,mergers and acquisitions has become one of essential ways for the pharmaceutical industry to become more bigger and stronger.In this paper,the financial benefits of the single specific Merger and acquisition activity is studied by a case study.This paper selects the event that Humanwell Healthcare Group CO.,LTD.mergers Yichang Three Gorges Pharmaceutical Limited company as a case study to analysis the impact of financial efficiency of enterprise merger and acquisition on the financial efficiency Whether is positive or negative.First of all,it introduces the purpose and significance of this study,literature review,research ideas and methods.Secondly,this paper introduces the definition of enterprise merger and acquisition,the theory of it,including efficiency theory,transaction cost theory and other theories,and Research methods.Quantitative financial index analysis method is mainly method.Then it introduces the background of the case,including the business situation of enterprises,the process and motive of it.After that,comprehensively analysis the corporate finance both of them,Analysis and evaluation of financial benefit after Merger and acquisition,which including two parts from Profitability to growth ability.Specifically,through the analysis of enterprise profit management,asset turnover,business ability,market development,enterprise competitiveness,and other aspects of the analysis,and comparing the important indicators before and after the Merger and acquisition activity,to determine the impact on merger and acquisition of financial humanwell is positive or negative.At last,the paper summarizes the case,puts forward the corresponding suggestions to the merger and acquisition activity,and prospects the development of the whole pharmaceutical industry.